EquityZen Growth Technology Fund LLC - Series 98
Raised
$284K
Investors
15
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 98 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC on 2017-08-03. The fund raised $284K from 15 investors under Rule 506(b) and 3(c)(1) exemptions. This is part of the EquityZen platform, which operates nearly 1,900 related pre-IPO investment vehicles.
This pre-IPO pooled fund uses the standard 506(b) private placement exemption paired with 3(c)(1) Investment Company Act exclusion, typical for single-company SPVs targeting accredited investors in late-stage private companies. The $19K average commitment per investor reflects EquityZen's model of fractionalizing access to individual pre-IPO positions into lower-entry pooled structures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.